Literature DB >> 27608174

Estimation of the number of people with Down syndrome in the United States.

Gert de Graaf1, Frank Buckley2,3, Brian G Skotko4,5.   

Abstract

PURPOSE: An accurate accounting of persons with Down syndrome (DS) has remained elusive because no population-based registries exist in the United States. The purpose of this study was to estimate this population size by age, race, and ethnicity.
METHODS: We predicted the number of people with DS in different age groups for different calendar years using estimations of the number of live births of children with DS from 1900 onward and constructing DS-specific mortality rates from previous studies.
RESULTS: We estimate that the number of people with DS living in the United States has grown from 49,923 in 1950 to 206,366 in 2010, which includes 138,019 non-Hispanic whites, 27,141 non-Hispanic blacks, 32,933 Hispanics, 6,747 Asians/Pacific Islanders, and 1,527 American Indians/American Natives. Population prevalence of DS in the United States, as of 2010, was estimated at 6.7 per 10,000 inhabitants (or 1 in 1,499).
CONCLUSION: Until 2008, DS was a rare disease. In more recent decades, the population growth of people with DS has leveled off for non-Hispanic whites as a consequence of elective terminations. Changes in childhood survival have impacted the age distribution of people with DS, with more people in their fourth, fifth, and sixth decades of life.Genet Med 19 4, 439-447.

Entities:  

Mesh:

Year:  2016        PMID: 27608174     DOI: 10.1038/gim.2016.127

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  60 in total

1.  Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome.

Authors:  Maria A Stanley; Nicole Shepherd; Nichole Duvall; Sandra B Jenkinson; Hasnaa E Jalou; Deborah C Givan; Gregory H Steele; Charlene Davis; Marilyn J Bull; Donna U Watkins; Randall J Roper
Journal:  Am J Med Genet A       Date:  2018-12-27       Impact factor: 2.802

2.  Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.

Authors:  Xiao-Fei Kong; Lisa Worley; Darawan Rinchai; Vincent Bondet; Puthen Veettil Jithesh; Marie Goulet; Emilie Nonnotte; Anne Sophie Rebillat; Martine Conte; Clotilde Mircher; Nicolas Gürtler; Luyan Liu; Mélanie Migaud; Mohammed Elanbari; Tanwir Habib; Cindy S Ma; Jacinta Bustamante; Laurent Abel; Aimé Ravel; Stanislas Lyonnet; Arnold Munnich; Darragh Duffy; Damien Chaussabel; Jean-Laurent Casanova; Stuart G Tangye; Stéphanie Boisson-Dupuis; Anne Puel
Journal:  J Clin Immunol       Date:  2020-06-22       Impact factor: 8.317

3.  Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Authors:  Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda Enriquez Estrada; Angela L Rachubinski; Jennifer A McWilliams; Ross Minter; Tiana Dimasi; Kelley L Colvin; Dmitry Baturin; Andrew T Pham; Matthew D Galbraith; Kyle W Bartsch; Michael E Yeager; Christopher C Porter; Kelly D Sullivan; Elena W Hsieh; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

4.  Family Sense-Making After a Down Syndrome Diagnosis.

Authors:  Lauren Clark; Heather E Canary; Kyle McDougle; Rebekah Perkins; Ruth Tadesse; Avery E Holton
Journal:  Qual Health Res       Date:  2020-07-03

5.  Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.

Authors:  Oguzhan Alagoz; Ali Hajjar; Sarocha Chootipongchaivat; Nicolien T van Ravesteyn; Jennifer M Yeh; Mehmet Ali Ergun; Harry J de Koning; Brian Chicoine; Barry Martin
Journal:  J Gen Intern Med       Date:  2019-08-05       Impact factor: 5.128

Review 6.  Down syndrome.

Authors:  Stylianos E Antonarakis; Brian G Skotko; Michael S Rafii; Andre Strydom; Sarah E Pape; Diana W Bianchi; Stephanie L Sherman; Roger H Reeves
Journal:  Nat Rev Dis Primers       Date:  2020-02-06       Impact factor: 52.329

Review 7.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

8.  The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.

Authors:  Ilaria Zuliani; Chiara Lanzillotta; Antonella Tramutola; Antonio Francioso; Sara Pagnotta; Eugenio Barone; Marzia Perluigi; Fabio Di Domenico
Journal:  Neurotherapeutics       Date:  2020-11-30       Impact factor: 7.620

9.  Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21).

Authors:  R B Cejas; M Tamaño-Blanco; J G Blanco
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

10.  The Test-Retest Reliability of the Bruininks-Oseretsky Test of Motor Proficiency-Short Form in Youth with Down Syndrome-A Pilot Study.

Authors:  Vincenzo G Nocera; Aaron P Wood; Angela J Wozencroft; Dawn P Coe
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.